USPTO serial 79416503
MEDICE
Reviewed by CopyMark Law Group
Status 760
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALBANO, ASHLEY C
- Law office
- TMEG LAW OFFICE 101
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MEDICE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MIKI MOTOHASHI IINO
Miki Motohashi Iino Millen, White, Zelano & Branigan, P.C.2200 Clarendon Boulevard Suite 1400Arlington, VA 22201United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietary supplements and dietetic preparations adapted for medical purposes; pharmaceutical preparations for the treatment of cough and cold and neuropsychiatric disorders; pharmaceutical preparations for skin care; pharmaceutical preparations for women's health, gastrointestinal health and nephrology for the treatment and prevention of menstrual symptoms, constipation, gastrointestinal diseases, kidney diseases and natural remedy preparations for the treatment of cough and cold and neuropsychiatric disorders; natural remedies for skin care, women's health, gastrointestinal health and nephrology, namely natural herbal supplements, natural dietary supplements, natural remedy preparations for the treatment of gastrointestinal diseases and conditions; vitamin and mineral preparations for medical use; veterinary preparations and substances for the treatment of infectious diseases and bacterial and viral infections; pharmaceutical preparations for veterinary use for the treatment of infectious diseases and bacterial and viral infections; pharmaceutical preparations for animals for the treatment of infectious diseases and bacterial and viral infections; nutritional supplements for veterinary use; medicinal healthcare preparations being medicinal herbal preparations; medicines for veterinary purposes for the treatment of infectious diseases and bacterial and viral infections; medical preparations for the treatment of cough and cold and neuropsychiatric disorders; medical preparations for skin care, women's health, gastrointestinal health and nephrology for the treatment and prevention of menstrual symptoms, constipation, gastrointestinal diseases, kidney diseases; chemical preparations for veterinary purposes namely, for the treatment of cough and cold and neuropsychiatric disorders; chemical preparations for veterinary purposes, namely, for skin care, women's health, gastrointestinal health and nephrology for the treatment and prevention of menstrual symptoms, constipation, gastrointestinal diseases, kidney diseases; chemical preparations for medical purposes namely, for the treatment of cough and cold and neuropsychiatric disorders; chemical preparations for medical purposes, namely, for skin care, women's health, gastrointestinal health and nephrology for the treatment and prevention of menstrual symptoms, constipation, gastrointestinal diseases, kidney diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 22, 2026 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jul 22, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 17, 2026 | ALIE | ASSIGNED TO LIE | — |
| Jul 15, 2026 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jul 15, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 15, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jul 15, 2026 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jul 15, 2026 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jul 15, 2026 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 6, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 5, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 15, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 15, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 15, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 11, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 11, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 27, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 11, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 11, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 8, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 7, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 8, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 8, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |